Kenneth Kovan

Kenneth Kovan

Net worth: 102 881 $ as of 31/07/2026

Health Technology
Consumer Services
Commercial Services

Profile

Kenneth E.
Kovan
is the founder of AVAX Technologies, Inc., founded in 1990.
Mr. Kovan is the founder of Bingham Hill Ventures, founded in 2012, holding the title of Managing Principal.
Mr. Kovan is also the founder of BioVaxys Technology Corp.,BioVaxys LLC.
Mr. Kovan is currently the President of Chaperone Technologies, Inc. Former positions include Principal at Thomas Jefferson University, Principal at GSK Plc, Principal at Wyeth-Ayerst Research, and Partner at Revvity Discovery Ltd.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/10/2025 935,286 ( 3.21% ) 102 881 $ 31/07/2026

Kenneth Kovan active positions

CompaniesPositionStart
BIOVAXYS TECHNOLOGY CORP. Founder -
President -
Founder -
Bingham Hill Ventures
Founder 01/01/2012

Former positions of Kenneth Kovan

CompaniesPositionEnd
Corporate Officer/Principal -
Wyeth-Ayerst Research
Corporate Officer/Principal -
GSK PLC Corporate Officer/Principal -
Corporate Officer/Principal -
AVAX TECHNOLOGIES, INC. Founder -
See the detail of Kenneth Kovan's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

10

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Health Technology

Wyeth-Ayerst Research

Health Technology

Commercial Services

Non-Energy Minerals

Health Technology

Bingham Hill Ventures